EUROPEAN NETWORK FOR HTA, JOINT ACTION 2, European project funded by the European Commission – acronym EUnetHTA JA2
The European Network in Health Technology Assessment (EuNetHTA) aims to implement effective and sustainable collaboration in the field of health technology assessment to achieve added value at European, national and regional level.
Network website: http://www.eunethta.eu/
FUNDING SOURCE: European Commission
PROJECT DURATION: 3 years (2013-2015)
PURPOSE: The current collaboration is a continuation of the previous EUnetHTA Joint Action 1 on HTA 2010-2012 project. This second phase focuses on strengthening the tools through transnational collaborative activities between HTA network members, resulting in the production of three HTA reports, based on the standardised model developed in phase 1 of the project (“Core Model HTA”), with the network members subsequently adapting and applying the model to local conditions.
SPECIFIC OBJECTIVES:
The overall objective is to test the implementation of the tools through an international collaborative approach in the field of HTA.
Joint Action 2 will lead to strengthening and improving collaboration within the EuNetHTA network so as to lead to a better understanding of how to establish a stable structure in the field of HTA at EU level.
The specific objective of JA2 is to develop an overall strategy containing principles and implementation proposals for sustainable collaboration at European level, in line with the stipulations of Article 15 of “The Directive for cross-border healthcare”.
Thus, the strategic objectives of JA2 are:
- Improving the implementation process of tools through an international collaborative approach to HTA
- Strengthen and improve collaboration within the EuNetHTA network so as to lead to a better understanding (by the EC and Member States) of how to establish a stable HTA structure at EU level
- Develop an overall strategy containing principles and implementation proposals for sustainable collaboration at European level, in line with the stipulations of Article 15 of “The Directive for cross-border healthcare”.